By Amber Roman
May 10, 2024, 1:35 PM EDT
The Colorado River toad, also called the Sonoran Desert toad, It is famous for its psychedelic poison, which it secretes when it feels threatenedand this poison is known to induce intense hallucinations.
However, until recently, scientists did not fully understand how this compound affects the human brain. A recent study has shed light on this issue, suggesting that The toad’s hallucinogenic compound could have potential as the basis for a new antidepressant.
The researchers focused on a modified form of a DMT compound and its interaction with a serotonin receptor known as 5-HT1A, involved in regulating mood and anxiety.
Although much of the research on psychedelics has focused on another serotonin receptor, 5-HT2A, which is activated during hallucinogenic experiences, the team led by pharmacologist Dr. Daniel Wacker of the Icahn School of Medicine opted to explore the effects of the compound on 5-HT1A receptors.
The scientists made chemical modifications to the toad’s venom so that it targeted specifically to the serotonin 5-HT1A receptors and tested it in mice exhibiting signs of stress and depression.
Antidepressant effects
The results were surprising: the compound derived from toad venom showed similar antidepressant and anxiolytic effects in mice, without inducing hallucinogenic effects.
Mice treated with the compound exhibited behaviors associated with decreased anxiety and depression, such as increased consumption of sugar water and increased social interaction. These findings are encouraging and suggest the compound’s potential as a treatment for mood disorders in humans.
However, researchers caution that more studies are needed to determine if these results translate into similar effects in humans. Although the study provides a promising foundation, there is still a long way to go before a treatment derived from toad venom can be available for clinical use.
Despite these advances, other psychedelics, such as psilocybin from magic mushrooms, are more likely to be approved as mental health therapies than any treatment based on toad venom.
Psilocybin has been the subject of research as a treatment for anxiety and depression, and scientists have noted its potential to help in difficult-to-treat cases. However, the study of toad venom offers a fascinating insight into the therapeutic potential of natural compounds in the treatment of mental illness.
The healing power of the venom of certain animals has sparked interest in medical research. Some compounds present in snake, scorpion and spider venoms have potential therapeutic properties.
For example, toxins are being studied to develop treatments for pain, neurological disorders and even heart disease. These compounds can modulate the activity of specific receptors in the human body, offering new perspectives in the fight against various conditions.
However, its therapeutic use is still in experimental stages and requires further studies to fully understand its efficacy and safety before widespread clinical application.
Keep reading:
- CDC has identified cases of HIV transmitted through cosmetic needles
- Global measles cases almost doubled in one year
- AI could trace the origins of metastatic cancer cells